These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29477413)

  • 41. Prolonged reversal of the phencyclidine-induced impairment in novel object recognition by a serotonin (5-HT)1A-dependent mechanism.
    Horiguchi M; Miyauchi M; Neugebauer NM; Oyamada Y; Meltzer HY
    Behav Brain Res; 2016 Mar; 301():132-41. PubMed ID: 26342283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
    Arvanov VL; Wang RY
    J Pharmacol Exp Ther; 1999 May; 289(2):1000-6. PubMed ID: 10215680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit.
    Terranova JP; Chabot C; Barnouin MC; Perrault G; Depoortere R; Griebel G; Scatton B
    Psychopharmacology (Berl); 2005 Aug; 181(1):134-44. PubMed ID: 15830220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment.
    Mouri A; Noda Y; Enomoto T; Nabeshima T
    Neurochem Int; 2007; 51(2-4):173-84. PubMed ID: 17669558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline.
    Fujita Y; Ishima T; Kunitachi S; Hagiwara H; Zhang L; Iyo M; Hashimoto K
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):336-9. PubMed ID: 17884273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats.
    Jentsch JD; Taylor JR
    Neuropsychopharmacology; 2001 Jan; 24(1):66-74. PubMed ID: 11106877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subchronic effects of phencyclidine on dopamine and serotonin receptors: implications for schizophrenia.
    Choi YK; Snigdha S; Shahid M; Neill JC; Tarazi FI
    J Mol Neurosci; 2009 Jul; 38(3):227-35. PubMed ID: 19455435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
    Nabeshima T; Mouri A; Murai R; Noda Y
    Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.
    Pichat P; Bergis OE; Terranova JP; Urani A; Duarte C; Santucci V; Gueudet C; Voltz C; Steinberg R; Stemmelin J; Oury-Donat F; Avenet P; Griebel G; Scatton B
    Neuropsychopharmacology; 2007 Jan; 32(1):17-34. PubMed ID: 16936709
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine.
    Guidali C; Viganò D; Petrosino S; Zamberletti E; Realini N; Binelli G; Rubino T; Di Marzo V; Parolaro D
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):17-28. PubMed ID: 20196921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801.
    Seillier A; Giuffrida A
    Behav Brain Res; 2009 Dec; 204(2):410-5. PubMed ID: 19716985
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential effects of acute and subchronic clozapine and haloperidol on phencyclidine-induced decreases in voluntary sucrose consumption in rats.
    Turgeon SM; Hulick VC
    Pharmacol Biochem Behav; 2007 Mar; 86(3):524-30. PubMed ID: 17320157
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia.
    Santini MA; Ratner C; Aznar S; Klein AB; Knudsen GM; Mikkelsen JD
    J Neurosci Res; 2013 May; 91(5):634-41. PubMed ID: 23404493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion.
    Jentsch JD; Taylor JR; Roth RH
    Neuropsychopharmacology; 1998 Aug; 19(2):105-13. PubMed ID: 9629564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin.
    Lee PR; Brady DL; Shapiro RA; Dorsa DM; Koenig JI
    Neuropsychopharmacology; 2005 Oct; 30(10):1883-94. PubMed ID: 15798779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of Subchronic Phencyclidine (PCP) Treatment on Social Behaviors, and Operant Discrimination and Reversal Learning in C57BL/6J Mice.
    Brigman JL; Ihne J; Saksida LM; Bussey TJ; Holmes A
    Front Behav Neurosci; 2009; 3():2. PubMed ID: 19255630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subchronic administration of phencyclidine produces hypermethylation in the parvalbumin gene promoter in rat brain.
    Fachim HA; Srisawat U; Dalton CF; Harte MK; Marsh S; Neill JC; Reynolds GP
    Epigenomics; 2016 Sep; 8(9):1179-83. PubMed ID: 27529801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synaptic transmission changes in fear memory circuits underlie key features of an animal model of schizophrenia.
    Pollard M; Varin C; Hrupka B; Pemberton DJ; Steckler T; Shaban H
    Behav Brain Res; 2012 Feb; 227(1):184-93. PubMed ID: 22085880
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Augmentation of locomotor activity by chronic phencyclidine is associated with an increase in striatal NMDA receptor function and an upregulation of the NR1 receptor subunit.
    Hanania T; Hillman GR; Johnson KM
    Synapse; 1999 Mar; 31(3):229-39. PubMed ID: 10029241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: implications for schizophrenia.
    Zavitsanou K; Nguyen V; Newell K; Ballantyne P; Huang XF
    J Chem Neuroanat; 2008 Oct; 36(2):71-6. PubMed ID: 18640263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.